SUMMARY OF QUALIFICATION Results oriented, high energy hands on professional with 20 years of experience in blood transfusion medicine, blood filtration technology, filter development, cryopreservation, lyophilization technology, biochemistry, hematology, medical research and product development with a very successful record of accomplishments. As a principal investigator, I successfully managed a highly successful research and development group of top scientists and I was able to successfully apply for and obtained funding from the USA Federal Government Department of Defense for new product development to assist in the treatment of combat causalities by providing life saving blood products. Successfully generated and developed original ideas that have resulted in significant financial benefits to Pall Corporation. Major strengths include strong scientific leadership, strong and exceptional problem solving skills that have been recognized both in academic and medical device industries, excellent communication skills, competent, strong team player, attention to detail, computer and internet literate as they relate to scientific research, advance knowledge of statistical tools that are needed for successful analysis and interpretation of complex scientific data that are needed to provide sound advice to CEOs and presidents of major biotech companies. Excellent reputation for writing clear and concise explanations for senior managements (CEOs, Presidents, Chairmen etc.) on complex scientific and medical subjects that will allow them to make sound judgment and investments in new biotechnologies. Dutiful respect for compliance in all regulated environment, as well as supervisory skills including hiring, termination, scheduling, training of research scientists and other scientific and technical tasks. Thorough knowledge of current research tools covering extensive multidisciplinary topics in haematology, blood banking, blood chemistry, transfusion medicine, biochemistry, chemistry, immunology, biophysics, manufacturing practices and a very clear vision to accomplish the company goals and objectives that will advance the interest and financial survival of a company. More recently, my scientific efforts have focused on the creation and development of a system that will reduce or prevent Transfusion Related Acute Lung Injury, the current leading cause of the morbidity and mortality associated with blood transfusion. By all accounts the results of this creative idea on a new product for TRALI have been excellent and recognized by experts in the field of Transfusion Medicine as having the potential to significantly reduce TRALI-related mortality and morbidity that are associated with the transfusion of red cell concentrates. In overview, I am responsible for strategic scientific and technical leadership and management of the basic science research program in blood for biomedical application.

Highlights:

• Research
• Research and Development
• Medical
• Banking Industry
• Benefits
• Biomedical Industry
• Cellular
• Hematology
• Immunology
• Manufacturing